Hildred Capital Management

Hildred Capital Management is a private equity firm focused on healthcare investments in North America and Europe. The firm specializes in operationally intensive, control-oriented investments in lower middle-market companies, partnering with innovative and growth-oriented management teams to build high-quality businesses. Hildred's team possesses extensive experience across the healthcare industry, leveraging a unique blend of strategic, financial, commercial, and operational acumen to drive strategic growth and create value for its portfolio companies and investment partners. As of January 2025, Hildred has more than $2.65 billion in assets under management.

The firm's investment strategy centers on identifying companies with solid fundamentals that have operational and scale-up needs to reach the next level of growth. Hildred seeks to reverse-solve for the path to value creation so that companies at exit are highly attractive and positioned for the long term. The firm aims to drive value through operational improvements—rather than multiple expansion and the aggressive use of debt—and designs its strategy to be repeatable across all markets and environments. Hildred's approach includes establishing sound overarching investment themes, exploring attractive opportunities across multiple markets and industry sub-sectors, and solidifying relationships with founders and management teams.

Hildred's commitment to its portfolio companies is evident in its recognition as a founder-friendly investor. In October 2024, the firm was named to Inc.'s 2024 List of Founder-Friendly Investors, honoring investment firms that remain actively involved with the businesses in which they invest and have earned the trust of the entrepreneurs they support. This recognition reflects Hildred's dedication to being a reliable, hands-on partner to its portfolio companies and their management teams, focusing on their long-term success and building great companies that add value to the healthcare system by improving patient outcomes, expanding access to high-quality care, and reducing costs.

Hildred's portfolio includes investments in companies such as Carlin Consumer Health, Crown Laboratories, Indentifeye Health, and DermCare Management. The firm continues to actively evaluate new investment opportunities, leveraging its deep industry knowledge and relationships to pursue control-oriented transactions in outstanding healthcare companies. Hildred remains committed to generating strong financial returns for its investors by tapping into secular growth opportunities across a range of subsectors in healthcare products and services, including commercial-stage pharmaceutical and OTC products, care delivery services, medical devices, life science tools and diagnostics, outsourced pharmaceutical and clinical services, and healthcare IT and tech-enabled services, as well as related businesses.